RXSTRxSight, Inc.

$313M

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$13M+118.0% YoY

Gross Profit

$5M42.5% margin

Operating Income

-$16M-126.5% margin

Net Income

-$17M-133.3% margin

EPS (Diluted)

$-0.61

QoQ Revenue Growth

+11.0%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$16M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$156M

Total Liabilities

$60M

Stockholders' Equity

$96M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$6M	+118.0%
Gross Profit	$5M	$1M	+299.4%
Operating Income	-$16M	-$13M	-21.7%
Net Income	-$17M	-$13M	-32.7%

Revenue Segments

L D D

$6M93%

Service Warranty Service Contracts And Accessories

$401,0007%

RXST Q3 2022 Earnings — RxSight, Inc. Revenue & Financial Results | Market Cap Arena